High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma.
about
The history and future of chemotherapy for melanoma.Recombinant interleukin-2 (rIL-2) with flavone acetic acid (FAA) in advanced malignant melanoma: a phase II study.Association between chemotherapy response and rate of disease progression in disseminated melanoma.High dose combination chemotherapy with ifosfamide, cyclophosphamide or cisplatin, mitomycin C and mustine with autologous bone marrow support in advanced non-small cell lung cancer. A phase I/II studyRecombinant interleukin-2 (rIL-2) given intrasplenically and intravenously for advanced malignant melanoma. A phase I and II study.
P2860
High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
High-dose, double alkylating a ...... metastatic malignant melanoma.
@en
High-dose, double alkylating a ...... metastatic malignant melanoma.
@nl
type
label
High-dose, double alkylating a ...... metastatic malignant melanoma.
@en
High-dose, double alkylating a ...... metastatic malignant melanoma.
@nl
prefLabel
High-dose, double alkylating a ...... metastatic malignant melanoma.
@en
High-dose, double alkylating a ...... metastatic malignant melanoma.
@nl
P2093
P1433
P1476
High-dose, double alkylating a ...... metastatic malignant melanoma.
@en
P2093
Chadwick G
Morgenstern G
Thatcher D
P2860
P304
P356
10.1002/1097-0142(19890401)63:7<1296::AID-CNCR2820630712>3.0.CO;2-3
P407
P577
1989-04-01T00:00:00Z